Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00818142 · ClinicalTrials.gov registry record

Support Group Surveys for Individuals Who Have Type 1 Diabetes and an Eating Disorder

A clinical trial of Type 1 Diabetes and Eating Disorder, sponsored by HealthPartners Institute.

Completed
Registry status
16
Enrollment target
1
Study location

NCT00818142: Completed study of Type 1 Diabetes and Eating Disorder, sponsored by HealthPartners Institute.

NCT00818142 is a study of Type 1 Diabetes and Eating Disorder that has completed, run by HealthPartners Institute. The registered enrollment target is 16 participants, below the 767-participant average among 198 other Type 1 Diabetes trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00818142, a study of Type 1 Diabetes and Eating Disorder, has completed, sponsored by HealthPartners Institute.

COMPLETED
Registry status
16 participants
Enrollment target
1
Study location

Study Summary

We propose to conduct a monthly group of persons with type 1 diabetes who also withhold insulin. Subjects will be asked to complete a 2-page survey (check-in sheet) at the beginning of each session and a 5-page survey (Diabetes and Eating Disorders Survey) on their first session and at their last session of their group.

Interventions

  • BEHAVIORAL ED/DM Support Group

Study Locations (1)

Minnesota

  • Park Nicollet Eating Disorder Institute - Minneapolis

Trial Details

FieldValue
Enrollment Target 16 participants
Start Date 2008-01
Est. Completion 2010-12
HealthPartners Institute

146 total trials

What the finished NCT00818142 record still lists

NCT00818142 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 16 participants, a relatively small participant target, below the 767-participant average among 198 other Type 1 Diabetes trials with a reported enrollment target (98% lower).

The record links to 2 conditions, with Type 1 Diabetes appearing as the primary indexed condition, and to 1 intervention - of which ED/DM Support Group is the first listed.

NCT00818142 reports a single indexed study location in Minnesota.

Frequently Asked Questions

What is clinical trial NCT00818142 about?

NCT00818142 is a clinical study titled "Support Group Surveys for Individuals Who Have Type 1 Diabetes and an Eating Disorder". We propose to conduct a monthly group of persons with type 1 diabetes who also withhold insulin. Subjects will be asked to complete a 2-page survey (check-in sheet) at the beginning of each session and a 5-page survey (Diabetes and Eating Disorders Survey) on their first session and at their last se...

What is the current status of trial NCT00818142?

This trial is currently completed. The enrollment target is 16 participants. The study started on 2008-01. Estimated completion is 2010-12.

What conditions does trial NCT00818142 study?

This clinical trial studies the following conditions: Type 1 Diabetes, Eating Disorder.

What interventions are being tested in trial NCT00818142?

The interventions under investigation include: ED/DM Support Group (BEHAVIORAL).

Who is sponsoring clinical trial NCT00818142?

This trial is sponsored by HealthPartners Institute, which has 146 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00818142 being conducted?

This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Type 1 Diabetes

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00818142's enrollment target sits among peer trials

16 162nd of 198 higher than 34 of 198 other Type 1 Diabetes trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Type 1 Diabetes trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02422641 · 16 participants · Phase 2

    Prospective Evaluation Of High-Dose Systemic Methotrexate In Patients With Breast Cancer And Leptomeningeal Metastasis

  • NCT02851758 · 16 participants · NA

    Transplantation of Autologously Derived Mitochondria Following Ischemia

  • NCT03291028 · 16 participants

    Analysis of Primary and Metastatic Tumors in Patients With Renal Cell Carcinoma and Urothelial Carcinoma

  • NCT03425526 · 16 participants · Phase 1

    Donor T Cell Therapy in Treating Immunocompromised Patients With Adenovirus-Related Disease

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00818142, the US trial registry maintained by the National Library of Medicine. NCT00818142 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.